CHICAGO, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) today announced that certain members of its management team will present at the 34th Annual J.P. Morgan Healthcare Conference, to be held Tuesday, January 12, 2016 at 8:30 a.m. PT in San Francisco, CA.
These presentations, where practicable, will be made available as a live webcast or audio recording at http://investor.allscripts.com under the "Webcasts and Presentations" section of the website.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2015 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact: Investors: Seth Frank 312-506-1213 [email protected] Media: Concetta DiFranco 312-447-2466 [email protected]


OpenAI Explores Massive Funding Round at $750 Billion Valuation
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 



